BIOMEDPHARMA — Atorvastatin Importer Profile
Pharmaceutical Importer · #2 buyer for Atorvastatin · $864.1K import value · 23 shipments · CANADA · DGFT Verified
BIOMEDPHARMA is the #2 importer of Atorvastatin from India with $864.1K in import value and 23 verified shipments. BIOMEDPHARMA holds a 0.1% market share in Atorvastatin imports based in CANADA. The company sources from 1 verified supplier across 13 formulations shipped to 1 country. Overall, BIOMEDPHARMA imports 2 pharmaceutical products worth $1.0M across 2 therapeutic categories.
BIOMEDPHARMA — Atorvastatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Atorvastatin to BIOMEDPHARMA?
Verified from 23 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $864.1K | 23 | 100.0% |
BIOMEDPHARMA sources Atorvastatin from 1 verified Indian supplier based on 23 customs records. The primary supplier is INTAS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Where Does BIOMEDPHARMA Import Atorvastatin To?
Destination countries from 23 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $864.1K | 23 | 100.0% |
BIOMEDPHARMA imports Atorvastatin to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $864.1K.
What Atorvastatin Formulations Does BIOMEDPHARMA Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS AND MEDI BIO ATORVASTATIN 20MG AS PER INVNOS | $149.5K | 3 |
| PHARMA DRUGS AND MEDI BIO ATORVASTATIN 20MG AS PER INV | $101.0K | 3 |
| PHARMA DRUGS AND MEDI BIO ATORVASTATIN 40MG 500TBIOMED#CAN AS PER INV | $100.0K | 2 |
| PH.DRU.& MED.: BIO ATORVASTATIN 40MG TABLETS (ATORVASTATIN CALCIUM TABLETS 40MG)[1X500T PER PACK] | $100.0K | 2 |
| PHARMA DRUGS AND MEDI BIO ATORVASTATIN 80MG 100T AS PER INVNOS | $59.0K | 3 |
| PHA.DRU & MEDI, BIO ATORVASTATIN 10MG 50 | $50.0K | 1 |
| PHA.DRU & MEDI, BIO ATORVASTATIN 80MG 10 | $50.0K | 1 |
| PHARMA DRUGS AND MEDI BIO ATORVASTATIN 1 | $50.0K | 1 |
| PHARMA DRUGS AND MEDI BIO ATORVASTATIN 80MG 100TBIOMED#CAN AS PER INV | $50.0K | 1 |
| PH.DRU.& MED.: BIO ATORVASTATIN 80MG TABLETS (ATORVASTATIN CALCIUM TABLETS 80MG)[1X100T PER PACK] | $50.0K | 1 |
BIOMEDPHARMA imports 13 distinct Atorvastatin formulations from India. The top formulation is PHARMA DRUGS AND MEDI BIO ATORVASTATIN 20MG AS PER INVNOS with 3 shipments worth $149.5K.
Regulatory Requirements: Importing Atorvastatin into Canada
What BIOMEDPHARMA and other importers must comply with to import Atorvastatin from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Atorvastatin
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Atorvastatin from India and How Much Does BIOMEDPHARMA Import?
India exported $152.2M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. BIOMEDPHARMA imports $864.1K of this total, accounting for 0.1% of India's Atorvastatin exports with 23 shipments from CANADA. This is verified from 23 customs shipment records covering 13 distinct formulations.
What Is the Average Order Value for BIOMEDPHARMA's Atorvastatin Imports?
BIOMEDPHARMA's average Atorvastatin order value is $37.6K per consignment, based on 23 shipments totaling $864.1K. BIOMEDPHARMA is based in CANADA and ranks #2 among all Atorvastatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Atorvastatin to BIOMEDPHARMA?
BIOMEDPHARMA sources Atorvastatin from 1 verified Indian supplier: INTAS PHARMACEUTICALS LIMITED ($864.1K, 100.0%). This is based on 23 customs records.
How Does BIOMEDPHARMA Compare to Other Atorvastatin Importers?
BIOMEDPHARMA ranks #2 among 1,291 Atorvastatin importers from India with a 0.1% market share. The top 3 importers are APL SWIFT SERVICES (MALTA) LTD., ($25.9M), APOTEX CORP ($21.4M), NOVADOZ PHARMACEUTICALS LLC ($17.3M). BIOMEDPHARMA processed 23 shipments from CANADA.
About BIOMEDPHARMA
BIOMEDPHARMA imports 2 products worth $1.0M. Beyond Atorvastatin, top products include Calcium. View the complete BIOMEDPHARMA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BIOMEDPHARMA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BIOMEDPHARMA's capped import value divided by total capped export value for Atorvastatin across all Indian exporters.
- 5.Verified Records: This page is backed by 23 individual customs records matching BIOMEDPHARMA importing Atorvastatin, covering 13 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Import Data for BIOMEDPHARMA
Access order-level details, pricing data, supplier connections, and competitive analysis for BIOMEDPHARMA's Atorvastatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BIOMEDPHARMA
Full Company Profile →
2 products · $1.0M total trade · 2 categories
BIOMEDPHARMA × Atorvastatin
Verified from customs records
Company Overview
Top Products by BIOMEDPHARMA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BIOMEDPHARMA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current order-level data, contact TransData Nexus.